Lv5
1054 积分 2024-10-26 加入
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
27天前
已完结
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
27天前
已完结
The landscape for in vivo CAR T cell therapies
1个月前
已关闭
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2个月前
已完结
Can multispecific biologics break the efficacy ceiling?
2个月前
已完结
Multispecific T-cell engagers attract cancer drug developers
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments
3个月前
已完结
Analyses of Recent Hit-Finding Campaigns for Difficult Targets Provides Guidance for Informed Integrated Hit Discovery
5个月前
已完结
皖公网安备34019202002308
